Literature DB >> 8824371

Pelvic inflammatory disease and risk of ovarian cancer.

F Parazzini1, C La Vecchia, E Negri, S Moroni, D dal Pino, L Fedele.   

Abstract

We analyzed the association between history of pelvic inflammatory disease (PID) and the risk of subsequent epithelial ovarian cancer, using data from a large case-control study conducted between 1983-1991 in Italy. Data were collected from a network of hospitals, including the main teaching and general hospitals in the greater Milan area, Northern Italy. The cases studied were 971 women below the age of 75 years (median age, 54 years) with histologically confirmed epithelial ovarian cancer, diagnosed within 1 year before the interview. Control subjects were 2758 women admitted to the same hospitals where cases were identified for acute, nonmalignant, nonhormone-related conditions, who had not undergone bilateral oophorectomy. The median age of the control group was 52 years (range, 23-74). A total of 14 (1.4%) cases and 72 (2.6%) controls reported a history of PID/ salpingitis, the corresponding multivariate relative risk being 0.7 (95% confidence interval, 0.4-1.3). A separate analysis of the association between history of PID/salpingitis and risk of ovarian cancer in strata of parity and education confirmed the results based on the whole series. In conclusion, although based on limited numbers of cases and controls with PID, this studies was able to exclude, at the conventional 95% confidence limit, an increased risk of ovarian cancer of over 30% in women with previous PID in this population.

Entities:  

Mesh:

Year:  1996        PMID: 8824371

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Rayna K Matsuno; Galina Lurie; Lynne R Wilkens; Michael E Carney; Brian E Henderson; Laurence N Kolonel; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

2.  Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.

Authors:  Zhiyi Zhou; Fangfang Zeng; Jianhui Yuan; Jinling Tang; Graham A Colditz; Shelley S Tworoger; Britton Trabert; Xuefen Su
Journal:  Cancer Causes Control       Date:  2017-03-24       Impact factor: 2.506

3.  Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.

Authors:  Hyo K Park; Joellen M Schildkraut; Anthony J Alberg; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Sydnee Crankshaw; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Paul Terry; Frances Wang; Julie J Ruterbusch; Ann G Schwartz; Michele L Cote
Journal:  Cancer Causes Control       Date:  2018-09-29       Impact factor: 2.506

Review 4.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

Review 5.  Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Authors:  Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen
Journal:  Am J Epidemiol       Date:  2016-12-09       Impact factor: 4.897

Review 6.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

7.  Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.

Authors:  Karin Malmberg; Charlotta Klynning; Angelique Flöter-Rådestad; Joseph W Carlson
Journal:  Virchows Arch       Date:  2016-03-22       Impact factor: 4.064

8.  High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population.

Authors:  Kasper Ingerslev; Estrid Hogdall; Wojciech Skovrider-Ruminski; Tine Henrichsen Schnack; Mona Aarenstrup Karlsen; Lotte Nedergaard; Claus Hogdall; Jan Blaakær
Journal:  Infect Agent Cancer       Date:  2016-07-14       Impact factor: 2.965

9.  Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

Authors:  Cheng-Che Shen; Li-Yu Hu; Albert C Yang; Yung-Yen Chiang; Jeng-Hsiu Hung; Shih-Jen Tsai
Journal:  BMC Cancer       Date:  2016-11-03       Impact factor: 4.430

10.  Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan.

Authors:  Cherry Yin-Yi Chang; Kent Yu-Hsien Lin; Chien-Chu Huang; Wu-Chou Lin
Journal:  BMC Womens Health       Date:  2021-07-28       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.